2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
trials, with less than half (43%) of all clinical trials occurring in any of the 113 low- and middle-income countries in scope of the 2024 Index. Collaborative activities, such as voluntary licensing agreements and technology transfers, are not being maximised by companies, with only two new non-exclusive voluntary licensing agreements identified in the 2024 Index, compared with six in 2022, and technology transfers concentrated in upper-middle-income countries rather than regions with the greatest need, such as sub-Saharan Africa. Companies must command further movement in the fight for global healthcare equity, using tried-and-tested mechanisms and new and innovative approaches, as well as leveraging their local partnerships, to meet their full potential in delivering their lifesaving treatments to patients, wherever they are needed, according to Jayasree K. Iyer, CEO, Access to Medicine Foundation. Five companies (Bristol Myers Squibb, Novartis, Novo Nordisk, Pfizer and Sanof
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- AbbVie gains on Leerink Partners upgrade to Outperform [Yahoo! Finance]Yahoo! Finance
- Is Bristol Myers Squibb Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks [Yahoo! Finance]Yahoo! Finance
- Effervescent Tablet Market to Grow by USD 4.80 Billion (2024-2028) as AI Impacts Market Trends, Rising Adoption Among Aging Population Boosts Revenue - Technavio [Yahoo! Finance]Yahoo! Finance
- Transplant Therapeutics Consortium Receives FDA Acceptance of the Qualification Plan for iBox Scoring System [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/24 - Beat
BMY
Sec Filings
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- BMY's page on the SEC website